Tob Control 22:i36-i37 doi:10.1136/tobaccocontrol-2012-050785
  • Commentary

Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products

Open Access
  1. Dorothy K Hatsukami
  1. Correspondence to Dr Dorothy K Hatsukami, Department of Psychiatry, University of Minnesota, 717 Delaware Street SE, Minneapolis, MN 55422, USA; hatsu001{at}
  • Received 18 September 2012
  • Revised 20 December 2012
  • Accepted 21 December 2012


The US Family Smoking Prevention and Tobacco Control Act and WHO Framework Convention on Tobacco Control provide us with powerful tools to reduce the death and disease caused by the use of tobacco products. One tool that can contribute substantially toward this goal is the authority to establish performance standards for tobacco products. Conjointly with reducing levels of nicotine in cigarettes, performance and quality control standards need to be established for non-combusted tobacco products. Performance standards and incentives should be provided so that tobacco companies are compelled to manufacture and market products with very low or almost non-existent toxicity (eg, nicotine-only products).

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: and

Open Access

Free sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Tobacco Control.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

This insightful video is produced by Cancer Research UK

Navigate This Article